Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline — Stella

Home/Brain Tumors/

View on ClinicalTrials.gov

Recruiting

Back to Brain Tumors trials

Trial locations(1 site)

India

Tata Memorial Hospital (TMH) Parel, and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Kharghar, Mumbai, Maharashtra

Key details

Sponsor

Tata Memorial Centre

Enrollment target

~200 participants

Started

February 2025

Primary completion

February 2032

Age range

5 Years – 39 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.